SCOLR Pharma, Inc. Reports Third Quarter 2007 Financial Results
MSN MoneyCentral - The Company believes that its cash, cash equivalents and short-term investments will be sufficient to fund its operations at planned levels through early 2008. Product Information Peramivir is the active ingredient in BioCryst’s

Panama Canal Program to Focus on Shifting Trade Routes
Forbes - Expanding this crucial trans-ocean shipping lane to accommodate more and larger ships presents a host of challenges and opportunities, ranging from increased trade to major new investments in water- and land-side transportation infrastructure. With a

HP Unveils Services and Solutions to Help Modernize, Manage SAP
Forbes - Together, we’re helping customers gain agility and greater return on their SAP application investments while reducing the cost of their SAP environments.” In a related move, SAP named HP a strategic Global Technology Partner for SAP ERP 6.0 Upgrades

From the Cubefiles Accounting Dept.